Thanks to Genenta Science and Pierluigi Paracchi for inviting us to the conference on the ๐๐ฉ๐ง๐๐ฉ๐๐๐๐ ๐๐ค๐ก๐ ๐ค๐ ๐ฝ๐๐ค๐ฉ๐๐๐๐ฃ๐ค๐ก๐ค๐๐ฎ ๐๐ค๐ง ๐ฉ๐๐ ๐ฟ๐๐ซ๐๐ก๐ค๐ฅ๐ข๐๐ฃ๐ฉ ๐ค๐ ๐พ๐ค๐ช๐ฃ๐ฉ๐ง๐ฎ ๐๐ฉ๐๐ก๐ฎ, held yesterday in Montecitorio.
Operating in the cell therapies sector, it is crucial also for us at Cellply that the Biotech sector becomes a driver for the development of our country.
#Biotech#CellTherapy
Leading innovation capabilities is an important part of our value proposition, and collaboration with universities is an important way to be in the forefront of R&D.
Mattia Spoldi, CEO of Euronovis Srl, was recently featured in the renowned Italian Pharmaceutical magazine, Notiziario Chimico Farmaceutico, regarding the innovative and impactful collaboration Euronovis fosters with the university.
"At Euronovis, we believe in the power of partnership and the fusion of industry and academia. Collaborations with universities are essential to drive creativity, pushing the boundaries of research and development, and nurturing the next generation of talent"
"Through these collaborations, we're able to tap into a source of fresh ideas and perspectives. Students bring a unique blend of enthusiasm and innovative thinking to our projects, the university brings the solidity of academic rigor, and we bring our industry experience to create real-world applications"
Read more about the collaboration below (paywall) or reach out if you want to learn more!
#Wellmaย #WellmaGroupย #Entrepreneurshipย #Nutraceuticals#pharma#TeamWellmaย #healthย #wellnessย ย #comanufacturingย #cdmoย #supplementsย ย #nutritionย #europeanleader#university
๐ A crucial step forward for HTL Biotechnology!
Read the Les Echos article: https://lnkd.in/eps25yPQ
We've therefore done it: very proud of our acquisition of the beauty and biomedical division of American company Modern Meadow and its human recombinant #collagen!
While we already have a production unit under construction in Massachusetts, the acquisition of this innovative recombinant protein platform is an opportunity for us to strengthen our American innovation cluster.
This acquisition will enable us to :
๐ Strengthen our position as global leader in pharmaceutical-grade biopolymers
ย ๐งฌ Diversify our range with a broad and unique offering of biopolymers
๐ก Innovate in our historical segments and in new therapeutic areas
๐ค Accelerate the innovation capabilities of our US and French teams through the complementarity and synergy of their expertiseย ย
ย ๐ฟ Free ourselves from collagens of animal origin, for eco-responsible and vegan solutions.
๐ Today we are living the 4ยฐ medical revolution thanks the genetics and gene-therapy.
๐งฌ I'm thrilled to represent Omzey at the firs ever high-level institutional and business meeting between Italy and US involved in #Biotech and #LifeScience
The managing directors of M Ventures, Hakan Goker and Owen Lozman, are the latest guests on the CVC Unplugged podcast, speaking about their investment strategy at the CVC arm of of German technology company Merck Group.
We talk about the leaps and bounds over the past decade in treating and finding cures for hard-to-treat ailments, how patient selection is an often overlooked but a crucial part of the drug discovery process, and why we should be optimistic about combatting disease.
https://lnkd.in/erh4UhvVM Ventures #AL#biotechnology#drugdiscovery
๐ญ๐งฌ ๐ง๐ต๐ฒ ๐๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐๐ถ๐ผ๐๐ฒ๐ฐ๐ต ๐ถ๐ ๐๐๐บ๐ฎ๐ป: ๐๐ผ๐ ๐๐๐ฟ๐ถ๐ผ ๐๐ถ๐ผ๐๐ฒ๐ฐ๐ต ๐๐๐ฑ ๐ถ๐ ๐๐น๐ถ๐บ๐ถ๐ป๐ฎ๐๐ถ๐ป๐ด ๐๐ป๐ถ๐บ๐ฎ๐น ๐ง๐ฒ๐๐๐ถ๐ป๐ด
Curio Biotech, a BioArk Visp-based startup, is transforming the landscape of product testing by utilizing human tissue instead of animal models. Their innovative #invitro studies deliver more relevant results for #cosmetics, #pharmaceuticals, and #nutraceuticals.
๐๐ฒ๐ ๐ต๐ถ๐ด๐ต๐น๐ถ๐ด๐ต๐๐ :
โก๏ธ Leverages discarded human tissue for cell isolation and testing
โก๏ธ Significantly reduces the need for #animalexperiments
โก๏ธ Provides customized research services focusing on primary #humancells
โก๏ธ Expanding portfolio in #autoimmunediseases and #cancer research
๐๐ปโ๏ธ Founder Chennakesava Cuddapah emphasizes: "๐๐ฆ ๐ฅ๐ฐ๐ฏ'๐ต ๐ถ๐ด๐ฆ ๐ข๐ฏ๐ช๐ฎ๐ข๐ญ๐ด ๐ง๐ฐ๐ณ ๐ฐ๐ถ๐ณ ๐ฆ๐น๐ฑ๐ฆ๐ณ๐ช๐ฎ๐ฆ๐ฏ๐ต๐ด, ๐ฃ๐ฆ๐ค๐ข๐ถ๐ด๐ฆ ๐ต๐ฆ๐ด๐ต๐ด ๐ฐ๐ฏ ๐ฉ๐ถ๐ฎ๐ข๐ฏ ๐ต๐ช๐ด๐ด๐ถ๐ฆ ๐ฑ๐ณ๐ฐ๐ท๐ช๐ฅ๐ฆ ๐ต๐ฉ๐ฆ ๐ฎ๐ฐ๐ด๐ต ๐ณ๐ฆ๐ญ๐ฆ๐ท๐ข๐ฏ๐ต ๐ช๐ฏ๐ง๐ฐ๐ณ๐ฎ๐ข๐ต๐ช๐ฐ๐ฏ ๐ง๐ฐ๐ณ ๐ฐ๐ถ๐ณ ๐ฃ๐ฐ๐ฅ๐ช๐ฆ๐ด."
Curio Biotech Ltd demonstrates how science-driven #innovation can lead to more #ethical and effective product development. Their work not only advances #research but also contributes to the reduction of #animaltesting. ๐๐ป
๐ Find out more about Curio Biotech Ltd in this interview by Philipp Mooser : https://lnkd.in/eRPh_tMn
๐๐ผ๐ ๐ฑ๐ผ ๐๐ผ๐ ๐๐ฒ๐ฒ ๐ถ๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป๐ ๐น๐ถ๐ธ๐ฒ ๐๐ต๐ถ๐ ๐๐ต๐ฎ๐ฝ๐ถ๐ป๐ด ๐๐ต๐ฒ ๐ณ๐๐๐๐ฟ๐ฒ ๐ผ๐ณ ๐ฏ๐ถ๐ผ๐๐ฒ๐ฐ๐ต?ย Let's discuss the potential impact on the industry here in the comments ๐๐ป
#biotech#innovation#ethicalresearch#swissstartupsStartupticker.chSwiss Healthcare StartupsBioAlps - Life Sciences Cluster ๐จ๐ญ Greater Geneva Bern area (GGBa)Promotion รฉconomique ValaisSwiss Biotech Association